| Literature DB >> 34304274 |
M De Pastena1, R Salvia1, S Paiella1, G Deiro1, E Bannone1, A Balduzzi1, T Giuliani1, L Casetti1, M Ramera1, C Filippini1, G Montagnini1, L Landoni1, A Esposito2,3.
Abstract
BACKGROUND: The study aims to assess the safety and feasibility of the robotic dual-console during a robotic distal pancreatectomyEntities:
Mesh:
Year: 2021 PMID: 34304274 PMCID: PMC8408081 DOI: 10.1007/s00268-021-06216-y
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Demographic, intraoperative, and pathological data
| Study population N = 102 | ||||
|---|---|---|---|---|
| Total n(%) | Dual-console group 42 (41%) | Standard group 60 (59%) | ||
| Age (years, DS) | 51 ± 16 | 51 ± 16 | 51 ± 15 | 0.810 |
| Sex (Female) | 73 (72%) | 28 (67%) | 45 (75%) | 0.243 |
| BMI (Kg/m2, IQR) | 23 [22–27] | 23 [20–29] | 23 [22–27] | 0.603 |
| Previous abdominal surgery | 42 (41%) | 20 (48%) | 22 (37%) | 0.184 |
| ASA score I-II | 94 (92%) | 37 (88%) | 57 (95%) | 0.183 |
| Spleen preservation | 35 (34%) | 17 (41%) | 18 (30%) | 0.188 |
| Conversion | 7 (7%) | 0 (0%) | 7 (12%) | |
| Pancreatic transection level | 0.568 | |||
| GDA | 2 (2%) | 0 (0%) | 2 (3%) | |
| Neck | 58 (57%) | 25 (60%) | 33 (56%) | |
| Distal | 42 (41%) | 17 (40%) | 25 (41%) | |
| Management stump | ||||
| Stapler | 33 (32%) | 23 (55%) | 10 (17%) | |
| Ultrasonic scalpel | 67 (66%) | 19 (45%) | 48 (80%) | |
| Duration of surgery (minutes, IQR) | 337 [260–401] | 410 [330–480] | 265 [230–330] | |
| EBL (cc, IQR) | 150 [100–250] | 150 [50–225] | 100 [100–275] | 0.811 |
| Pathology, No. (%) | 0.687 | |||
| PDAC | 10 (10%) | 5 (12%) | 5 (8%) | |
| Cystic lesions | 28 (27%) | 9 (21%) | 19 (32%) | |
| pNET | 42 (41%) | 18 (43%) | 24 (40%) | |
| Other | 22 (22%) | 10 (24%) | 12 (20%) | |
| Tumor size (mm, DS) | 31±22 | 30 ± 20 | 32 ± 23 | 0.661 |
| Harvest lymph nodes (DS) | 15 ± 12 | 15 ± 11 | 14 ± 12 | 0.666 |
Statistically significant values (p < 0.05) are given in bold
ASA: American society of anesthesiology; BMI: Body mass index; GDA: Gastroduodenal artery; MCN: Mucinous cystic neoplasm; pNET: Pancreatic neuroendocrine tumor; SPT: Solid pseudopapillary tumor
Fig. 1Timeline recruitment
Postoperative data
| Study population N = 102 | ||||
|---|---|---|---|---|
| Total n(%) | Dual-console group 42 (41%) | Standard group 60 (59%) | ||
| Overall morbidity | 44 (43%) | 17 (41%) | 27 (45%) | 0.402 |
| Major complications | 10 (10%) | 2 (5%) | 8 (13%) | 0.136 |
| CCI | 10 ± 14 | 9 ± 14 | 11 ± 15 | 0.631 |
| POPF | 29 (28%) | 13 (31%) | 16 (27%) | 0.400 |
| PPH | 9 (9%) | 2 (5%) | 7 (12%) | 0.199 |
| Length of stay (days, IQR) | 7 [6–10] | 7 [7–10] | 7 [6–10] | 0.618 |
| Reoperation | 8 (8%) | 1 (2%) | 7 (12%) | 0.086 |
| Readmission | 12 (12%) | 2 (5%) | 10 (17%) | 0.060 |
CCI: Comprehensive complication index; POPF: Postoperative pancreatic fistula; PPH: Post pancreatectomy hemorrhage